Cyclooxygenase-2 expression on urothelial and inflammatory cells of cystoscopic biopsies and urine cytology as a possible predictive marker for bladder carcinoma

APMIS

Volumn 117, Issue 1, 2009, Pages 45-52

  Moussa, Mona ^b   Omran, Zeinab ^b   Nosseir, Mona ^a,b   Lotfy, Abeya ^b   Swellam, Tarek ^b  

^a Imbaba   (Egypt)

^b THEODOR BILHARZ RESEARCH INSTITUTE   (Egypt)

Author keywords

Bladder carcinoma; COX 2; Cystoscopic biopsies; Inflammatory cells; Urine cytology; Urothelial cells

Indexed keywords

CYCLOOXYGENASE 2; FORMALDEHYDE; POLYCLONAL ANTIBODY;

ADULT; ARTICLE; BLADDER BIOPSY; BLADDER CARCINOMA; CONTROLLED STUDY; CYSTITIS; CYSTOSCOPY; DOWN REGULATION; DYSPLASIA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; MAJOR CLINICAL STUDY; MALE; PRECANCER; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; SQUAMOUS CELL METAPLASIA; TRANSITIONAL CELL CARCINOMA; URINE CYTOLOGY; UROTHELIUM;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CARCINOMA, TRANSITIONAL CELL; CYCLOOXYGENASE 2; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MALE; MIDDLE AGED; PRECANCEROUS CONDITIONS; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS; URINE; UROTHELIUM;

EID: 58649117592     PISSN: 09034641     EISSN: 16000463     Source Type: Journal    
DOI: 10.1111/j.1600-0463.2008.00014.x     Document Type: Article

References (38)

1. Mokhtar N, Gouda I, Adel I. Malignant urinary system tumors. In : Cancer Pathology Registry (2003-2004) and Time Trend Analysis, Chapter 3. Cario : Department of Pathology, NCI, 2007 : 32 8.
2. Rosin MP, Anwar WA, Ward AJ. Inflammation, chromosomal instability and cancer: the schistosomiasis model. Cancer Res 1994 54 : 1929s 33s.
3. Xu XC. Cyclooxgenase-2 inhibitors in cancer treatment and prevention: a recent development. Anticancer Drugs 2002 13 : 127 37.
4. Shirahama T. Molecular oncology, markers, clinical correlates: cyclooxygenase-2 expression is up-regulated in transitional cell carcinoma and its preneoplastic lesions in the human urinary bladder. Clin Cancer Res 2000 6 : 2424 30.
5. Tsujii M, Kawano S, Dubios RN. Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc Natl Acad Sci USA 1997 94 : 3336 40.
6. Li G, Yang T, Li L, Yan J, Zeng Y, Yu J, et al. Cyclooygenase-2 parallels invasive depth and increased MVD in transitional cell carcinoma. Coll. Surf B Biointer 2004 37 : 9 15.
7. Kiyishima K, Oda Y, Kinukawa N, Naito S, Tsuneyoshi M. Overexpression of laminin-5 gamma 2 chain and its prognostic significance in urothelial carcinoma of urinary bladder: association with expression of cyclooxygenase 2, epidermal growth factor receptor and human epidermal growth factor receptor 2. Hum Pathol 2005 36 : 522 30.
8. Wadhwa P, Goswami AK, Joshi K, Sharma SK, et al. Cyclooxygenase-2 expression increases with the stage and grade in transitional cell carcinoma of the urinary bladder. Int Urol Nephrol 2005 37 : 47 53.
9. Tortora G, Capulo R, Damiano V, Melisi D, Bianco R, Fontanini G, et al. Combination of selective cyclooxygenase-2 inhibitor with epidermal growth factor receptor tyrosine kinase inhibitor ZD 1839 and protein kinase A antisense causes cooperative anti-tumor and anti-angiogenic effect. Clin Cancer Res 2003 9 : 1556 72.
10. Marks F, Fürstenberger G, Müller-Decker K. Tumor promotion as a target of cancer prevention. Recent Results Cancer Res 2007 174 : 37 47.
11. Zhang J, Xu ZQ, Hu Q, Qiu XW, Wang ZR, et al. Effects of selective cyclooxygenase-2 inhibitor on proliferation and apoptosis of human bladder cancer cell line T24. Ai Zheng 2007 26 : 377 81.
12. Dhawan D, Jeffreys AB, Zheng R, Stewart JC, Knapp DW, et al. Cyclooxygenase-2 dependent and independent antitumor effects induced by celecoxib in urinary bladder cancer cells. Mol Cancer Ther 2008 7 : 897 904.
13. Epstein JI, Amin MB, Reuter VR, Mostofi FK. The Bladder Consensus Conference Committee. The WHO/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Am J Surg Pathol 1998 22 : 1435 48.
14. Rosai J. Rosai and Ackerman's Surgical Pathology, 9th ed. Vol. 6. Amsterdam : Elsevier Inc. Appendix C, staging of cancer 2004 : 2833 4.
15. Maranchie JK, Boutounes BT, Zhang PL, O'Donnell M, Summerhayes I, DeWolf W. Clinical and pathological characteristics of micro-papillary transitional cell carcinoma: a highly aggressive variant. J Urol 2000 163 : 748 51.
16. Yoshimura R, Sano H, Mitsuhashi M, Kohno M, Chargui J, Wada S. Expression of cyclooxygenase-2 in patients with bladder carcinoma. J Urol 2001 165 : 1468 72.
17. Snedecor GW, Cochran WG. One way classification analysis of variance. In : Snedecor GW, Cochran WG, editors. Statistical Methods. Ames, IA : Iowa State University Press, 1979 : 258.
18. Wang KJ, Li H, Wei Q, Yang YR. Expression of cyclooxygenase in bladder transitional cell carcinoma. Sichuan Da Xue Xue Bao Yi Xue Ban 2004 35 : 54 6.
19. Mohammed SI, Knapp DW, Bostwick DG, Foster RS, Khan KNM, Masferrer JL, et al. Expression of cyclooxygenase-2 (COX-2) in human invasive transitional cell carcinoma (TCC) of the urinary bladder. Cancer Res 1999 59 : 5647 50.
20. Ren L, Hou SK, He LF, Ye HY, Guan KP. The significance of the expression of cyclooxygenase-2 in bladder transitional cell carcinoma tissues. Zhonghua Wai Ke Za Zhi 2004 42 : 1104 7.
21. Ristimaki A, Nieminen O, Saukkonen K, Hotakainen K, Nordling S, Haglund C. Expression of cyclooxygenase-2 in human transitional cell carcinoma of the urinary bladder. Am J Pathol 2001 158 : 849 53.
22. Shirahama T, Sakakura C. Overexpression of cyclooxygenase-2 in squamous cell carcinoma of the urinary bladder. Clin Cancer Res 2001 7 : 558 61.
23. Müller-Decker K, Fürstenberger G. The cycclooxygenase-2-medited prostaglandin signaling is causally related toepithelial carcinogenesis. Mol Carcinog 2007 46 : 705 10.
24. Komhoff M, Guan Y, Shappell HW, Davis L, Jack G, Shyr Y, et al. Enhanced expression of cyclooxygenase-2 in high grade human transitional cell carcinomas. Am J Pathol 2000 157 : 29 35.
25. Shariat Sf, Kim JH, Ayala GE, Kho K, Wheeler TM, Lerner SP. Cyclooxygenase-2 is highly expressed in carcinoma in situ and T1 transitional cell carcinoma of the bladder. J Urol 2003 169 : 938 42.
26. Zhan J, Tang XD. Expression of cyclooygenase-2 in human transitional cell bladder carcinomas. Ai Zheng 2002 21 : 1212 6.
27. Mokos I, Jakić-Razumović J, Mareković Z, Pasini J. Association of cyclooxygenase-2 immunoreactivity with tumor recurrence and disease progression in superficial urothelial bladder cancer. Tumori 2006 92 : 124 9.
28. El-Sheikh SS, Madaan S, Alhasso A, Abel P, Stamp G, Lalani E-N. Cyclooxygenase-2: a possible target in schistosoma-associated bladder cancer. BJU Int 2001 88 : 921 7.
29. Bartoletti R, Cai T, Nesi G, Sardi I, Rizzo M. Qualitative and quantitative analysis of angiogenetic factors in transitional cell bladder carcinoma: relationship with clinical course at 10 years followup. Oncol Rep 2005 14 : 251 5.
30. Eltze E, Wulfing C, Von Struensee D, Piechota H, Buerger H, Hertle L. COX-2 and Her2/neu co-expression in invasive bladder cancer. Int J Oncol 2005 26 : 1525 31.
31. Wulfing C, Eltze E, Von Struensee D, Wülfing P, Bode ME, Bettendorf O, et al. Cyclooxygenase-2 expression in bladder cancer: tumor biological and clinical implications. Aktuelle Urol 2004 35 : 331 8.
32. Shirahama T, Arima J, Akiba S, Sakakura C. Relation between cyclooxygenase-2 expression and tumor invasiveness and patient survival in transitional cell carcinoma of the urinary bladder. Cancer 2001 92 : 188 93.
33. Wu XR. Urothelial tumorigenesis: a tale of divergent pathways. Nat Rev Cancer 2005 5 : 713 25.
34. Mao LP. Evaluation of urine COX-2 protein, NMP22 and exfoliative cytology in diagnosis of bladder carcinoma. Clin J Clin Urol 2007 2 :.
35. Vamvakas S, Schmidt HH. Just say no to cancer? J Natl Cancer Inst 1997 89 : 406 7.
36. Tamatani T, Turk P, Weitzman S, Oyasu R. Tumorigenic conversion of rat urothelial cell line by human polymorphonuclear leucocytes activated by lipopolysaccharide. Jpn J Cancer Res 1999 90 : 829 30.
37. Sun Z, Yang P. Role of imbalance between neutrophil elastase and alpha 1-antitrypsin in cancer development and progression. Lancet Oncol 2004 5 : 182 90.
38. Ghanem LY, Lotfy AA, Moussa MM, Saadaby Z. Ultrastructural alterations of inflammatory cells in bladder cystitis versus bladder carcinoma. J Egypt Soc Hematol Res 2005 1 : 17 22.